You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
普萊柯(603566.SH):雙葛止瀉顆粒獲得新獸藥註冊證書
格隆匯 02-21 16:18

格隆匯2月21日丨普萊柯(603566.SH)公佈,根據《獸藥管理條例》和《獸藥註冊辦法》規定,農業農村部經審查,批准普萊柯生物工程股份有限公司及全資子公司洛陽惠中獸藥有限公司、河南新正好生物工程有限公司等公司聯合申報的“雙葛止瀉顆粒”為新獸藥,並於2022年2月21日公示了核發《新獸藥註冊證書》(中華人民共和國農業農村部公吿第528號)事項。

該產品於2019年7月向河南省畜牧局提交臨牀試驗申請,經後續臨牀試驗、新獸藥註冊等階段,農業農村部於2022年2月21日公吿核發新獸藥註冊證書,截至目前該項目累計投入研發費用226.09萬元。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account